2018 Spain HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
This DataPack presents Spanish test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:
Contains 60 pages and 7 tables
- Hospitals
- Commercial/Private Labs
- Blood Banks
Contains 60 pages and 7 tables
Major Companies Developing or Marketing AIDS Tests
Spain: HIV or HIV1/2/Comb Test Volume and Sales Forecast by Market Segment
Spain: HIV Ag Test Volume and Sales Forecast by Market Segment
Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Spain: HIV or HIV1/2/Comb Test Volume and Sales Forecast by Market Segment
Spain: HIV Ag Test Volume and Sales Forecast by Market Segment
Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
More Publications
2017-2021 France HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
January 2017
-
France HIV/AIDS Diagnostics Market 2017-2022: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,450.00
January 2018
-
2017-2021 HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts
US$ 4,905.00
January 2017
288 pages
Global HIV/AIDS Diagnostics Market 2017-2022: Supplier Country Shares, Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures--HIV 1/2, Combo, Ag, NAT, Western Blot--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
US$ 5,450.00
January 2018
288 pages
U.S. HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Forecasts, 2019-2023
US$ 1,850.00
July 2019
250 pages